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Eukaryotic transporters for 
hydroxyderivatives of benzoic acid
Andrea Cillingová1, Igor Zeman1, Renáta Tóth2, Martina Neboháčová1, Ivana Dunčková1, 
Mária Hölcová1, Michaela Jakúbková1, Gabriela Gérecová1,6, Leszek P. Pryszcz3,7,  
Ľubomír Tomáška  1, Toni Gabaldón3,4,5, Attila Gácser2 & Jozef Nosek  1
Several yeast species catabolize hydroxyderivatives of benzoic acid. However, the nature of carriers 
responsible for transport of these compounds across the plasma membrane is currently unknown. 
In this study, we analyzed a family of genes coding for permeases belonging to the major facilitator 
superfamily (MFS) in the pathogenic yeast Candida parapsilosis. Our results revealed that these 
transporters are functionally equivalent to bacterial aromatic acid: H+ symporters (AAHS) such as 
GenK, MhbT and PcaK. We demonstrate that the genes HBT1 and HBT2 encoding putative transporters 
are highly upregulated in C. parapsilosis cells assimilating hydroxybenzoate substrates and the 
corresponding proteins reside in the plasma membrane. Phenotypic analyses of knockout mutants 
and hydroxybenzoate uptake assays provide compelling evidence that the permeases Hbt1 and Hbt2 
transport the substrates that are metabolized via the gentisate (3-hydroxybenzoate, gentisate) 
and 3-oxoadipate pathway (4-hydroxybenzoate, 2,4-dihydroxybenzoate and protocatechuate), 
respectively. Our data support the hypothesis that the carriers belong to the AAHS family of MFS 
transporters. Phylogenetic analyses revealed that the orthologs of Hbt permeases are widespread in 
the subphylum Pezizomycotina, but have a sparse distribution among Saccharomycotina lineages. 
Moreover, these analyses shed additional light on the evolution of biochemical pathways involved in 
the catabolic degradation of hydroxyaromatic compounds.
The major facilitator superfamily (MFS) proteins represent the largest group of secondary carriers involved in 
various transport processes including uniport, solute: cation symport and solute: H+ or solute: solute antiport. 
These permeases are usually 400–600 amino acids long, form either 12 or 14 transmembrane α-helices (TMH) 
and exhibit specificity for a wide range of substrates including sugars, amino acids, nucleosides, lipids, metabolic 
intermediates, ions and drugs. They are classified into about 100 families based on their sequence similarity, 
substrate specificity and mechanism of action (reviewed in refs 1–7). Bacterial MFS transporters mediating the 
uptake of aromatic acids belong to several families including ACS (anion: cation symporter; e.g. OphD, OphP, 
Pht1)8–10, AAHS (aromatic acid: H+ symporter; e.g. BenK, GenK, MhbT, PcaK)11–14 and MHS (metabolite: H+ 
symporter; e.g. MopB, PcaT, ShiA)15–17. Moreover, carriers from other superfamilies such as ABC (ATP-binding 
cassette; e.g. OphFGH)10, APC (amino acid-polyamine-organocation; e.g. BenE)18 and OMPP (outer membrane 
pore-forming protein; e.g. BenP)19 also transport aromatic substrates.
Pioneering studies20, 21 on the basidiomycete Trichosporon cutaneum uncovered an inducible energy-dependent 
uptake system for phenol and demonstrated that phenolate anions are co-transported with protons in stoichiom-
etry 1:1. The symport with H+ ion was also shown for vanillate in another basidiomycete Fomitopsis palustris22. 
However, the genes encoding these transporters have not yet been identified. In human cells, sodium-coupled 
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monocarboxylate transporter for short-chain fatty acids (SMCT1, SLC5A8) is involved in the uptake of nicotinate 
and various aromatic monocarboxylates including benzoate and salicylate23.
In this study, we analyzed the genes from the pathogenic yeast Candida parapsilosis that encode MFS per-
meases for hydroxyderivatives of benzoic acid. This yeast utilizes various hydroxyaromatic substrates via the 
gentisate (i.e. 3-hydroxybenzoate, 2,5-dihydroxybenzoate (gentisate)) and 3-oxoadipate (i.e. hydroquinone, resor-
cinol, 4-hydroxybenzoate, 2,4-dihydroxybenzoate (β-resorcylate) and 3,4-dihydroxybenzoate (protocatechuate)) 
pathway24–26. The range of catabolized substrates differs among closely related species that are classified into the 
CTG clade of Saccharomycotina. For example, Candida orthopsilosis assimilates hydroxybenzenes and hydrox-
ybenzoates via the 3-oxoadipate pathway, but lacks the gentisate pathway. On the other hand, Candida albicans, 
Candida dubliniensis and Candida tropicalis catabolize mono- and dihydroxybenzenes, but not hydroxybenzo-
ates26. This metabolic diversity indicates that C. parapsilosis possesses functional transporter(s) for hydroxyben-
zoates and the species like C. albicans may lack such carriers. As the genomes of several CTG clade species were 
sequenced and annotated27–34, hydroxybenzoate transporter genes could be identified by means of comparative 
and functional genomics.
The C. parapsilosis genome encodes 138 predicted MFS proteins (Pfam clan CL0015). Although they have 
not been functionally characterized, computational analyses indicated role(s) for many of them based on their 
sequence homology to transporters with known functions35–37. However, none of them has a predicted role in 
the uptake of hydroxybenzoates. Moreover, BlastP searches with queries derived from bacterial hydroxybenzoate 
permeases (i.e. MhbT for 3-hydroxybenzoate13, PcaK for 4-hydroxybenzoate and protocatechuate12 and GenK for 
gentisate14) did not reveal any significant hit. We therefore reasoned that, similarly to the enzymes catalyzing reac-
tions of the gentisate and 3-oxoadipate pathways26, 38, 39, the hydroxybenzoate transporters could be upregulated 
in C. parapsilosis cells grown in media containing a hydroxybenzoate as a sole carbon source. Indeed, an RNA-seq 
experiment revealed two candidate genes CPAR2_704330 and CPAR2_204840 coding for predicted MFS trans-
porters that are highly induced in the cells assimilating 3-hydroxybenzoate and 4-hydroxybenzoate, respectively. 
Although corresponding proteins were previously classified into drug: H+ antiporter family 1 (DHA1)37, results 
of the functional analysis clearly demonstrate that both permeases are involved in the uptake of hydroxybenzoates 
presumably by proton symport mechanism.
Results and Discussion
Identification of the genes for hydroxybenzoate transporters. Initially we attempted to search for 
candidate genes encoding the hydroxybenzoate transporters by blasting the C. parapsilosis genome using the 
amino acid sequences of bacterial transporters for aromatic acids classified into different superfamilies such as 
ABC, APC, MFS and OMPP (Supplementary Table S1). The searches with all but one bacterial query did not 
reveal any clear candidate for hydroxybenzoate carriers (E-values were above 10−25). In case of the phthalate 
permease OphD from Burkholderia cepacia, the best identified hits were CPAR2_802720 and its three paralogs 
CPAR2_802710, CPAR2_802700 and CPAR2_802690 (E-values were 2 × 10−35 to 2 × 10−30). These genes are 
tandemly arranged on the chromosomal contig005807 and the analysis of deduced amino acid sequences pre-
dicted MFS_1 domain (PF07690) and twelve TMHs (except CPAR2_802690, which appears to be truncated at its 
N-terminus). Similarly to OphD, the C. parapsilosis proteins as well as the C. albicans CR_01220 W (an ortholog 
of CPAR2_802720) can be classified into the ACS family of MFS transporters9, 35.
Next, we compared the expression of predicted plasma membrane transporter genes in cells assimilating 
3-hydroxybenzoate, 4-hydroxybenzoate or glucose by RNA-seq analysis. Our results showed that the transporter 
gene with the highest level of expression in the control cells grown in synthetic medium containing glucose (SD) 
was CPAR2_212860 encoding an MFS protein with predicted sugar transporter domain (PF00083/Sugar_tr). 
Its ortholog in C. albicans is HGT7 (C2_01000 W) and codes for a glucose transporter40, 41. We assumed that 
CPAR2_212860 may have similar function in C. parapsilosis. In contrast to SD medium, the most expressed genes 
in synthetic media containing a hydroxybenzoate are CPAR2_704330 (S3OH) and CPAR2_204840 (S4OH) that 
code for uncharacterized members of the MFS. These genes have no orthologs in C. albicans, which metabolizes 
hydroxybenzenes, but does not assimilate hydroxybenzoates, further supporting the idea that they are associated 
with the hydroxybenzoate metabolism. The expression of both genes was nearly undetectable on glucose, but they 
were highly upregulated in media containing a hydroxybenzoate (Supplementary Table S2). CPAR2_704330 was 
induced more than 1,402-fold on S3OH and CPAR2_204840 more than 1,247-fold on S4OH. Such strong induc-
tion was observed only on one hydroxybenzoate indicating that corresponding transporters could be specific for 
the substrate present in the cultivation medium.
Of the four OphD homologs identified by the BlastP searches, the highest level of expression has 
CPAR2_802720 on S4OH medium, where it exhibits 1,378-fold induction. In spite of such high induction, the 
overall transcript level of CPAR2_802720 was more than 14 times lower than observed for CPAR2_204840 and 
its paralogs (i.e. CPAR2_802710, CPAR2_802700 and CPAR2_802690) were weakly expressed on all three media 
(Supplementary Table S2).
BlastP searches using CPAR2_704330 and CPAR2_204840 as queries identified additional two uncharacter-
ized MFS proteins, CPAR2_100470 and CPAR2_100460. These hits had E-values below 10−80, while all remaining 
hits had E-values above 10−25. The amino acid sequences of CPAR2_704330, CPAR2_204840, CPAR2_100470 and 
CPAR2_100460 display extensive sequence similarity (Supplementary Fig. S1), possess a typical MFS_1 domain 
and twelve TMHs (Supplementary Fig. S2). All four proteins belong to the Pfam clan CL0015 (Supplementary 
Table S2). Previously, they were classified into the drug: H+ antiporter 1 (DHA1) family (2.A.1.2)37. However, our 
phylogenetic analysis indicates that the sequences of all four C. parapsilosis proteins cluster with typical AAHS 
permeases (Supplementary Fig. S3). Therefore, we propose that these proteins are eukaryotic members of the 
AAHS family (2.A.1.15). Their sequences exhibit less than 20% overall identity with the bacterial AAHS carriers 
such as BenK, GenK, PcaK and MhbT and lack a typical ‘DGXD’ motif present in the TMH 1. Nonetheless, a 
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more detailed sequence comparison revealed several similarities with the bacterial transporters. The hydrophilic 
regions between the TMHs 2-3 and 8-9 contain conserved motifs ‘VPXMX(R/A)YG(K/R)(R/K)’ and ‘G(Y/P)
(M/L)SDX(L/W)(V/M)X(W/R)’, respectively (Supplementary Fig. S4). These motifs resemble to the consensus 
‘GXXXD(R/K)XGR(R/K)’, which in bacterial MFS permeases has a role in the substrate transport42. Importantly, 
the aspartate residue in the motif present within the loop between TMHs 8 and 9, which is conserved in the entire 
AAHS family, occurs also in the C. parapsilosis transporters. In addition, charged residues R124, E144, R386 
and R398 present in the sequence of Pseudomonas putida PcaK43 were found also in the C. parapsilosis proteins 
(i.e. the arginines occur in the positions corresponding to R124 and R398; a glutamic acid is in E144 (except for 
CPAR2_704330, which has an aspartic acid in this position); and a lysine replaces R386). Moreover, the amino 
acid sequence alignment revealed several additional residues (i.e. G92, G165, P287, G310, G368 according to the 
PcaK numbering) that are shared by bacterial and C. parapsilosis proteins (Supplementary Fig. S1). Importantly, 
some of the amino acid residues conserved between the bacterial AAHS and C. parapsilosis proteins were shown 
to be essential for activity of the AAHS transporters (Supplementary Table S3). Based on the sequence analysis 
and the experimental results shown below we named these genes as HBT1 (for hydroxybenzoate transporter 1; 
CPAR2_704330), HBT2 (CPAR2_204840), HBT3 (CPAR2_100470) and HBT4 (CPAR2_100460).
The HBT1 gene is located between the genes MNX2 (CPAR2_704320) and GDX1 (CPAR2_704340), within 
the metabolic gene cluster coding for the gentisate pathway enzymes26 and the phylogenetic analysis showed 
that it co-evolved with other genes present in this cluster39 further supporting its association with the gentisate 
pathway.
Quantitative RT-PCR analysis of the expression of HBT genes. To confirm the data obtained by 
the RNA-seq experiment and to further investigate the expression of HBT1-HBT4 genes, we analyzed the levels 
of corresponding transcripts by qPCR in cells cultivated in synthetic media containing a hydroxyaromatic com-
pound (i.e. 3-hydroxybenzoate, 4-hydroxybenzoate, 2,4-dihydroxybenzoate, gentisate, protocatechuate, hydro-
quinone and resorcinol), a respiratory substrate (glycerol and ethanol) or glucose as a sole carbon source. In these 
assays, we used the expression of MNX1 (4-hydroxybenzoate 1-hydroxylase) and MNX2 (3-hydroxybenzoate 
6-hydroxylase) as markers showing the activation of the 3-oxoadipate and gentisate pathway, respectively. MNX1 
is strongly induced on the substrates of the 3-oxoadipate pathway (1,243-fold on 4-hydroxybenzoate, 1,101-fold 
on protocatechuate, 886-fold on 2,4-dihydroxybenzoate, 113-fold on resorcinol and 66-fold on hydroquinone), 
but also on gentisate (259-fold) and to a lesser extent on 3-hydroxybenzoate (15.6-fold), which are catabolized via 
the gentisate pathway. In contrast, MNX2 is highly upregulated on 3-hydroxybenzoate (884-fold) and gentisate 
(240-fold) but it exhibits lower induction on hydroquinone (75-fold), 4-hydroxybenzoate (30-fold), protocate-
chuate (9.8-fold) and resorcinol (3.2-fold).
The expression of HBT1 is strongly induced on both gentisate pathway substrates (i.e. 1,117-fold on genti-
sate and 843-fold on 3-hydroxybenzoate), but also on hydroquinone (785-fold), which enters the 3-oxoadipate 
pathway. However, this gene exhibits only modest induction in media with the remaining hydroxyaromatic sub-
strates. HBT2 is induced on all substrates degraded via the 3-oxoadipate pathway (i.e. 414-fold on hydroquinone, 
171-fold on resorcinol, 118-fold on 4-hydroxybenzoate, 61-fold on 2,4-dihydroxybenzoate and 57-fold on pro-
tocatechuate) as well as on gentisate (489-fold). The induction of both HBT3 and HBT4 is noticeably lower when 
compared to HBT1 or HBT2. We observed a slight induction of HBT3 on 4-hydroxybenzoate (8.1-fold), gentisate 
(6.2-fold), hydroquinone (5.1-fold), protocatechuate (2.9-fold) and resorcinol (2.5-fold). HBT4 was induced on 
hydroquinone (11.7-fold), gentisate (10.2-fold) and resorcinol (8.7-fold) (Fig. 1, Supplementary Table S4). These 
results demonstrate that all four HBT genes are upregulated in a substrate-dependent manner in cells assimilating 
a hydroxyaromatic compound.
Phenotypic analysis of Δhbt mutants. The expression profiles of HBT genes indicated that correspond-
ing protein products could be involved in the uptake of hydroxyaromatic compounds. To test this idea, we con-
structed a set of homozygous knockout strains each lacking a single HBT gene. In standardized phenotypic tests 
(Supplementary Table S5) we observed that the growth of Δhbt1/Δhbt1, Δhbt2/Δhbt2 and Δhbt3/Δhbt3 strains 
in complex (YPD) as well as synthetic media (SD1%, SD1% + FBS, YCB + BSA), the colony morphology, the for-
mation of pseudohyphae, the sensitivity to oxidative stress (H2O2), detergents (SDS), the inhibitors of cell wall 
biosynthesis (calcofluor white, congo red, caffeine), hygromycin B and antifungal drugs (caspofungin, flucona-
zole) remain unchanged when compared to the wild type strain. The phenotype of the Δhbt4/Δhbt4 mutant 
was similar, except its slower growth in synthetic media at 20 °C, formation of smaller colonies on SD1% plates, 
resistance to caffeine and altered sensitivity to both antifungals (Supplementary Table S5, Supplementary Fig. S5).
Next, we tested the ability of mutant strains to grow in synthetic media containing a hydroxybenzoate as a 
sole carbon source (Fig. 2a,b). We observed impaired growth of the mutants Δhbt1/Δhbt1 and Δhbt2/Δhbt2 in 
media with substrates assimilated via the gentisate and 3-oxoadipate pathway, respectively. The phenotypes were 
more pronounced in media buffered to pH 7.5 (Fig. 2b) possibly reflecting the fact that pKa values of all hydrox-
ybenzoates are lower than 5. This may cause that in non-buffered media (at pH below 3.5) the hydroxyaromatic 
substrates are at least partially present in their undissociated form, which may enter the cells by a simple diffu-
sion. In contrast to strains Δhbt1/Δhbt1 and Δhbt2/Δhbt2, the mutants Δhbt3/Δhbt3 and Δhbt4/Δhbt4 do not 
exhibit growth defect in these media. This may suggest that Hbt3 and Hbt4 are not involved in hydroxybenzoate 
uptake or their affinity to these compounds substantially differ from that of Hbt1 and Hbt2 (e.g. Hbt1 and Hbt2 
may represent high-affinity and Hbt3 and Hbt4 low-affinity transporters). In the latter case, Hbt1 and/or Hbt2 
would compensate the growth defects resulting from the absence of Hbt3 and Hbt4 proteins.
To verify that the phenotypes of Δhbt1/Δhbt1 and Δhbt2/Δhbt2 strains are caused by deletions of the trans-
porter gene and to localize corresponding proteins within the C. parapsilosis cells, we transformed both mutants 
using the plasmids expressing the Hbt proteins tagged with the yEGFP3 at their C-termini. This experiment 
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confirmed that pPK5-HBT1 and pPK5-HBT2 complement corresponding mutations. In addition, we observed 
that pPK5-HBT1 suppresses the growth defect also in the Δhbt2/Δhbt2 mutant suggesting that Hbt1 transports 
both 3-hydroxybenzoate and protocatechuate, although the native HBT1 gene is differentially regulated in cells 
assimilating these substrates (Fig. 1). However, pPK5-HBT2 does not functionally complement the Δhbt1 muta-
tion. We also found that neither Δhbt1/Δhbt1 nor Δhbt2/Δhbt2 cells transformed with the plasmid pPK5-HBT3 
can grow in media containing 3-hydroxybenzoate (Δhbt1/Δhbt1) or protocatechuate (Δhbt2/Δhbt2) suggesting 
that Hbt3 does not participate in the uptake of these substrates (Fig. 3).
The examination of the transformants by fluorescence microscopy showed that the fusion proteins 
Hbt1-yEGFP3 and Hbt2-yEGFP3 are localized on the cell surface, presumably in the plasma membrane (Fig. 4).
Uptake of [14C]-labeled hydroxybenzoates. To investigate the transport of hydroxybenzoates into C. 
parapsilosis cells, we analyzed the uptake of [14C]-labeled substrates (i.e. 3-hydroxybenzoate, 4-hydroxybenzoate 
and protocatechuate; Fig. 5). Our results showed that the wild type cells transport all three substrates, although 
the overall accumulated radioactivity in cells was substantially higher with [14C]3-hydroxybenzoate than 
[14C]4-hydroxybenzoate or [14C]3,4-dihydroxybenzoate. These differences may at least partially result from dif-
ferent levels of HBT1-4 transcripts in the cells grown in S3OH, SHyd and S3,4diOH media (Fig. 1, Supplementary 
Table S2). Alternatively, corresponding transporters may exhibit different affinities to these substrates. The 
hydroxybenzoate uptake cannot be attributed to a simple diffusion as the assays were performed at pH 7.5, 
where about 99% of the substrate is present as a hydroxybenzoate anion that does not pass through the plasma 
membrane.
To examine if the transport of hydroxybenzoates is dependent on proton gradient, we treated the wild type 
cells with a protonophore (100 µM CCCP) prior addition of [14C]3-hydroxybenzoate to the uptake assay. We 
found that CCCP almost completely inhibits the substrate uptake (Table 1) thus confirming that the transport is 
driven by proton gradient across the plasma membrane.
In contrast to the wild type cells, the uptake of [14C]3-hydroxybenzoate is almost completely abolished 
in the Δhbt1/Δhbt1 mutant (Fig. 5a). This indicates that Hbt1p is the major carrier for this substrate. The 
impaired growth of this mutant in S3OH and S2,5diOH (Fig. 2) further suggests that Hbt1p can transport both 
Figure 1. Relative mRNA expression of C. parapsilosis genes coding for hydroxybenzoate transporters (HBT1-4) 
and monooxygenases (MNX1-2). Bar graph showing the fold change of the HBT1-4, MNX1 and MNX2 mRNA 
levels in cells grown on depicted substrates relative to the mRNA levels in cells assimilating glucose (SD). The 
assays were performed in at least three independent experiments with two parallel replicates in each case and the 
values of mean and SEM/SD are shown in Supplementary Table S4.
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3-hydroxybenzoate as well as gentisate. The uptake of [14C]3-hydroxybenzoate is decreased by 21, 26 and 29% also 
in Δhbt2/Δhbt2, Δhbt3/Δhbt3 and Δhbt4/Δhbt4 cells, respectively. The reason for reduced transport capacity 
of these mutants remains unclear. However, it seems unlikely that Hbt2, Hbt3 and Hbt4 contribute to the uptake 
of 3-hydroxybenzoate as the cells lacking Hbt1 apparently do not transport this substrate. To analyze the kinet-
ics of 3-hydroxybenzoate transport, we examined the uptake of this substrate in eight concentrations ranging 
from 0.5 to 150 µM. Our results showed that 3-hydroxybenzoate is transported into the wild type cells with Vmax 
0.63 ± 0.05 nmol/min/mg of dry weight and Km 21.58 ± 6.58 µM (Supplementary Fig. S6) indicating that, simi-
larly to bacterial AAHS permeases (e.g. GenK, MhbT and PcaK)12–14, Hbt1 is a high-affinity transporter.
The experiments with [14C]4-hydroxybenzoate and [14C]3,4-dihydroxybenzoate revealed that the uptake of 
both substrates is impaired in the ∆hbt2/∆hbt2 mutant but not in other strains (Fig. 5b–d). The growth defect 
Figure 2. Utilization of hydroxybenzoates by C. parapsilosis mutants. The wild type strain CLIB214 and the hbt 
mutants were grown overnight in liquid YPD medium at 28 °C, washed with water, diluted to a concentration 
6 × 106 cells/ml. Serial fivefold dilutions were then spotted on the synthetic media containing either glucose or 
a hydroxybenzoate substrate as a sole carbon source. The plates were incubated for 4 days at 28 °C. The yeast 
strains were cultivated in unbuffered media (a) as well as in the media with pH adjusted to 7.5 using 100 mM 
Tris-HCl (b).
Figure 3. Functional complementation of the Δhbt1 and Δhbt2 mutations. The mutants Δhbt1/Δhbt1 and 
Δhbt2/Δhbt2 were transformed with the pPK5-derived plasmid constructs carrying either HBT1, HBT2 or 
HBT3 gene. The transformants were cultivated overnight in SD + MPA medium at 28 °C, washed with water, 
diluted to concentration 5 × 105 cells/ml and plated in fivefold dilutions onto indicated synthetic media buffered 
with 100 mM Tris-HCl to pH 7.5. The plates were incubated for 7 days at 28 °C. Transformants with the vector 
pPK5 were used as a control.
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Figure 4. Intracellular localization of Hbt1 and Hbt2 proteins. The cells transformed with pPK5, pPK5-HBT1 
and pPK5-HBT2 plasmids were grown overnight in SD + MPA medium at 28 °C, washed with water and the 
expression of yEGFP3-tagged proteins was induced for 2–4.5 hours by cultivation in SGal + MPA medium. The 
cells were examined by fluorescence microscopy (Olympus BX50).
Figure 5. Uptake of [14C]-labeled hydroxybenzoates. C. parapsilosis cells CLIB214 (wild type) and mutants 
lacking individual Hbt carriers were grown in unbuffered synthetic media containing a hydroxyaromatic 
compound as a sole carbon source. The uptake assays were then performed as described in the Methods section. 
C. parapsilosis cells grown in S3OH (a) S4OH (b) and SHyd (c,d) medium were used in the uptake assays of 
[14C]3-hydroxybenzoate (a) [14C]4-hydroxybenzoate (b,c) and [14C]3,4-dihydroxybenzoate (d), respectively. 
The assays were performed in three independent experiments with two parallel measurements in each case 
(mean ± SEM).
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of this strain in S4OH, S2,4diOH and S3,4diOH indicates that Hbt2p can transport all three hydroxybenzoates 
catabolized via the 3-oxoadipate pathway (Fig. 2).
In most cases, the MFS permeases transport their substrates into cells along with H+ ions1, 44. The hydroxyar-
omatic anion: H+ symport systems were demonstrated in bacteria12, 45 as well as in basidiomycetes T. cutaneum 
(phenolate)20 and F. palustris (vanillate)22. The amino acid sequence similarity of the Hbt proteins and bacterial 
AAHS transporters as well as the dependence of hydroxybenzoate uptake on the proton gradient led us to con-
clusion that C. parapsilosis Hbt proteins also function as proton symporters. We posit that Hbt1p and Hbt2p are 
involved in the uptake of hydroxybenzoates degraded via the gentisate and 3-oxoadipate pathway, respectively. 
The role of Hbt3p and Hbt4p remains elusive and will require further investigation.
Phylogeny of HBT genes and the evolution of hydroxybenzoate catabolism. Aromatic com-
pounds derived from lignin in decaying plant tissues are catabolized via biochemical pathways operating in spe-
cies from all three kingdoms of life (reviewed in ref. 46). In C. parapsilosis, the catabolism of hydroxybenzoates 
proceeds via the gentisate pathway and the hydroxyhydroquinone (HHQ) variant of the 3-oxoadipate pathway 
(Fig. 6). These pathways include activities of monooxygenases with broader substrate specificity (Mnx1, Mnx2, 
Mnx3) and dioxygenases (Hdx1, Gdx1) that open the aromatic ring of the catabolized compounds. Resulting 
products are then converted via several reactions to intermediates entering the central metabolism (e.g. tricarbo-
xylic cycle). In contrast to C. parapsilosis, C. albicans lacks the gentisate pathway and possesses the catechol and 
HHQ variants of the 3-oxoadipate pathway24–26, 38. As C. albicans does not have a homolog of decarboxylating 
Strain 1 min 2 min 3 min 4 min
wild type 100 100 100 100
wild type + 100 µM 
CCCP 3.85 ± 0.38 4.83 ± 1.54 4.09 ± 0.74 3.68 ± 0.50
∆hbt1/∆hbt1 4.12 ± 1.66 1.68 ± 0.52 0.95 ± 0.08 0.56 ± 0.10
Table 1. The uptake of [14C]3-hydroxybenzoate is blocked by protonophore and in the absence of Hbt1p. 
Results of the assay are expressed as the percentage (±SEM) of the wild type cells untreated with CCCP.
Figure 6. Degradation of hydroxybenzenes and hydroxybenzoates in the yeasts C. parapsilosis and  
C. albicans. The two Candida species differ in biochemical pathways involved in degradation of 
hydroxyaromatic substrates as well as in the transport systems for these compounds. While C. parapsilosis 
assimilates both hydroxybenzenes and hydroxybenzoates, C. albicans utilizes a wider range of hydroxybenzenes, 
but not hydroxybenzoates. Although the HHQ variant of the 3-oxoadipate pathway operates in both species, 
C. albicans lacks decarboxylating monooxygenase Mnx1 and hydroxybenzoate transporter Hbt2, which are 
present in C. parapsilosis. Mnx1 and Hbt2 are paralogous to Mnx2 and Hbt1, respectively, that are involved in 
the gentisate pathway. Note that C. parapsilosis proteins Mnx3 and Hdx1 are orthologous to C. albicans proteins 
Phh1/Phh2 and Hqd1, respectively.
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monooxygenase catalyzing the first step of the 3-oxoadipate pathway (i.e. Mnx1 in C. parapsilosis) and lacks 
homologs of the Hbt transporters, it can utilize hydroxybenzenes, but not hydroxybenzoates (Fig. 6).
The difference between the two Candida species belonging to the CTG clade of Saccharomycotina could result 
from either a downgrade or an upgrade of corresponding metabolic pathways. In the first scenario, a common 
ancestor of the CTG clade species possessed the two branches of the 3-oxoadipate pathway as well as the gentisate 
pathway and it could catabolize both hydroxybenzoates and hydroxybenzenes. The gentisate pathway gene cluster 
and the genes coding for decarboxylating monooxygenase (Mnx1) and hydroxybenzoate transporters have been 
lost in the C. albicans lineage causing its inability to assimilate hydroxybenzoates. On the other hand, the C. par-
apsilosis lineage lost the genes for the catechol branch of the 3-oxoadipate pathway. Alternatively, an ancestor of 
both species possessed the catechol branch and a shorter version of the HHQ variant of the 3-oxoadipate pathway 
allowing the degradation of hydroxybenzenes (i.e. as it occurs in C. albicans) and the gentisate pathway. The genes 
encoding the enzymes of the latter pathway and the catechol variant of the 3-oxoadipate pathway have been lost in 
the lineages leading to C. albicans and C. parapsilosis, respectively. In the C. parapsilosis lineage, the duplications 
of HBT1 and MNX2 would generate HBT2 and MNX1, respectively, and led to an upgrade of the HHQ variant of 
the 3-oxoadipate pathway to allow the uptake and decarboxylation of hydroxybenzoates.
To examine these possibilities, we performed phylogenetic analysis of hydroxybenzoate transporters and 
their homologs (Fig. 7, see Methods). We found that the HBT1 orthologs are widespread in Pezizomycotina 
(e.g. Aspergillus and Penicillium species), but that their distribution among Saccharomycotina is very sparse. In 
the latter subphylum, the orthologs were identified in several species of the CTG clade (i.e. Candida maltosa, 
Debaryomyces hansenii, Debaryomyces fabryi, Lodderomyces elongisporus, Scheffersomyces stipitis, Spathaspora 
passalidarum) as well as in species classified outside of this phylogenetic branch (i.e. Brettanomyces bruxellensis, 
Kuraishia capsulata, Nadsonia fulvescens, Sugiyamaella lignohabitans). HBT2 orthologs show a more sparse dis-
tribution which is almost restricted to the CTG clade, with the sole exception of Wickerhamomyces anomalus. 
The distribution within the CTG clade only partially overlaps with that of Hbt1, being present in several common 
species (i.e. C. parapsilosis, D. hansenii, D. fabryi, L. elongisporus, S. passalidarum) and some additional species 
(C. orthopsilosis, M. guilliermondi). Importantly, our comparative and phylogenetic analyses suggest that Hbt1 
and Hbt2 transporters show a high level of sequence divergence, and with the associations of these two clades 
receiving only weak phylogenetic support. Considering our obtained topology (Fig. 7a), the most parsimonious 
phylogenetic scenario suggests that Hbt1 and Hbt2 diverged within the Saccharomycotina but much before the 
origin of the CTG clade. Differential losses from a common ancestor would have resulted in the current sparse 
distribution. Finally, our analysis identified that the closer paralogs to HBT2 (i.e. HBT3 and HBT4) emerged from 
a specific duplication in the C. parapsilosis complex species (i.e. C. orthopsilosis and C. parapsilosis).
Vertical descent from a common ancestor of Saccharomycotina was proposed for evolution of the metabolic 
gene cluster encoding the gentisate and 3-oxoadipate pathway enzymes38, 39. Phylogenetic distribution of the 
HBT paralogs correlates with the ability to grow on hydroxybenzoates. Hence, the duplication of HBT1 followed 
by functional specialization of HBT2 could extend the range of hydroxybenzoate substrates metabolized via the 
3-oxoadipate pathway, supporting the upgrading scenario. However, our analysis indicates that this occurred a 
long time ago, before the divergence of the CTG clade from other Saccharomycotina, and that subsequent loss in 
some lineages resulted in the secondary loss of this ability.
As mentioned above, the upgrade of the 3-oxoadipate pathway requires a decarboxylation of a hydroxybenzo-
ate substrate. In C. parapsilosis, this reaction is catalyzed by 4-hydroxybenzoate 1-hydroxylase (Mnx1), which has 
broad substrate specificity and utilizes 4-hydroxybenzoate, 2,4-dihydroxybenzoate and protocatechuate26, 47. This 
enzyme has a distant paralog Mnx2 (3-hydroxybenzoate 6-hydroxylase) catalyzing the first reaction of the genti-
sate pathway. The phylogenetic analysis of Mnx1 and Mnx2 indicates that their emergence from a common ances-
tor is also evolutionarily ancient and occurred before the divergence of the CTG clade from a Saccharomycotina 
ancestor. Based on the phylogenies of Hbt1-4 and Mnx1-2 proteins (Fig. 7) we assume that the ancestor pos-
sessed the gentisate pathway as well as the longer version of the 3-oxoadipate pathway, but had limited capacity 
for the hydroxybenzoate uptake as it possessed only the Hbt1 transporter. This limitation was overcome by the 
HBT1 gene duplication and subsequent specialization of the Hbt2 transporter. Many subsequent lineages have 
lost either of the pathways, given rise to their sparse distributions with little overlap that we see today. Thus, we 
propose a combined model, implying one ancient upgrade followed by multiple independent downgrades. Of 
note, HBT1 duplications seem to be common. However, the phylogenetic analysis indicates that these paralogs 
emerged independently of HBT2.
Conclusions
The yeast C. parapsilosis possesses MFS carriers Hbt1 and Hbt2 mediating the inducible proton driven transport 
system for hydroxybenzoates catabolized via the gentisate and 3-oxoadipate pathway, respectively. These trans-
porters are functionally related to bacterial AAHS permeases and represent the first identified eukaryotic mem-
bers of this family. Functional characterization of these carriers may contribute to exploration of yeast species 
in bioremediation of environments contaminated with toxic aromatic pollutants and utilization of compounds 
derived from lignin and decaying plant tissues.
Methods
Yeast cultivations. C. parapsilosis CLIB214 (identical to CBS604, the wild type strain) and its mutant deriv-
atives were cultivated in synthetic and complex media listed in Table 2. The sensitivity to acidic and alkaline 
conditions was tested in YPD media with pH ranging from 4 to 8. pH of the respective media was adjusted 
using McIlvaine (citrate-phosphate) buffer. The temperature sensitivity was examined in YPD medium at 20, 
30 and 37 °C for 48 hours. The growth kinetics was assessed in liquid YPD medium for 24 hours at 30 °C with 
hourly measurements at OD600. The viability was also monitored in the presence of various stressors applied in 
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serial twofold dilutions in six steps. The following stressors were used: calcofluor white (0.1 mg/ml), congo red 
(0.1 mg/ml), caffeine (0–50 mM), H2O2 (7.5 mM), sodium dodecyl sulfate (SDS, 0.1% (w/v)) and hygromycin B 
(0.0156 mg/ml). The survival relative to the stressor-free control was monitored by measurements at OD600. The 
formation of pseudohyphae was analyzed in DMEM + FSB medium after 24 and 48 hours at 37 °C. In exper-
iments aimed at the functional analysis of HBT genes, the cells were grown at 28 °C in synthetic media con-
taining a hydroxyaromatic compound, glucose, galactose, glycerol or ethanol as a sole carbon source (Table 2). 
Hydroxyaromatic compounds were dissolved in dimethyl sulfoxide (DMSO) as 0.5 M stocks. Where indicated, 
pH of the medium was adjusted to 7.5 using 100 mM Tris-HCl prior addition of a carbon source. For solid media, 
agar was added to 2% (w/v).
Preparation of knockout strains. The mutants lacking an individual HBT gene were generated using a 
previously established method, adapted for C. parapsilosis48, 49. Briefly, the disruption of a gene was achieved 
via auxotrophy complementation of the double auxotrophic strain named CPL2H1 (C. parapsilosis his−/leu− 
derived from CLIB214). Deletion constructions contained the upstream (UpFw primer 1 and UpRev primer 3; 
Figure 7. Relevant partitions of the reconstructed phylogenies of the genes HBT1 and HBT2 (a) MNX1 (b) and 
MNX2 (c). Every tree shows the largest monophyletic clade containing the seed sequence (HBT1, MNX1 and 
MNX2, respectively) and their Saccharomycotina homologs. The subtrees have been rooted at the closest non-
Saccharomycotina homologs. The branches with low support (aLRT < 0.5) are shown with an asterisk.
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Supplementary Table S6) and downstream (DownFw primer 4 and DownRev primer 6) homologous regions of 
the target open reading frame (ORF) and either Candida dubliniensis HIS1 or Candida maltosa LEU2 sequences 
as selection markers. Coding sequences of HIS1 and LEU2 were amplified from the plasmids pSN52 and pSN40, 
respectively48, 49, using the primer 2 and 5. Joining of the amplified products was achieved using polymerase chain 
reaction (PCR). Deletion cassettes were transformed into CPL2H1 strain and the transformants were plated onto 
selective media. Obtained heterozygous and homozygous mutant strains were verified by colony PCR using the 
primers specific for both the marker sequences and the outside of the integration sites at both the upstream and 
downstream homologous regions. Mutant strains were further tested for the gene expression using quantitative 
PCR (qPCR).
Gene expression analysis. Total cellular RNA was isolated from the culture of the wild type strain grown 
in synthetic media with appropriate carbon source by the phenol-chloroform extraction protocol50 and the RNA 
preparations were treated with RNase-free DNase I (New England Biolabs) according to the manufacturer’s 
instructions. The RNA-seq and real-time qPCR analyses were performed as described previously39. The sequenc-
ing reads have been deposited to Short Read Archive (PRJEB1707). The gene-specific primers used for qPCR 
assays are shown in Supplementary Table S6.
Plasmid constructs. The C. parapsilosis sequences coding for Hbt1, Hbt2 and Hbt3 proteins were amplified 
by PCR using the gene specific primers (Supplementary Table S6) and the template from the genomic DNA of 
the wild type strain. The PCR products containing the ORFs without the termination codon, plus 700 nucleotides 
upstream of the initiation codon, were inserted into the SalI site of the pPK5 vector51 using the Gibson assembly 
cloning kit (New England Biolabs). The cloned genes containing native promoters are placed downstream of the 
GAL1 promoter in the resulting plasmid constructs.
Functional complementation of Δhbt mutants and fluorescence microscopy. Plasmid DNAs 
were introduced into Δhbt cells by electroporation52 and transformants were selected on media containing myco-
phenolic acid (SD + MPA). The utilization of hydroxybenzoates was tested in synthetic media containing glucose 
or a hydroxybenzoate as a sole carbon source. The cells transformed with the vector pPK5 were used as a negative 
control. For intracellular localization of Hbt proteins C-terminally tagged with yeast-enhanced green fluorescent 
protein 3 (yEGFP3), the transformants were cultivated overnight in SD + MPA medium at 28 °C, washed with 
water and the expression of fusion proteins was induced for 2–4.5 hours in SGal + MPA medium. Intracellular 
localization of Hbt1-yEGFP3 and Hbt2-yEGFP3 was investigated by fluorescence microscopy using BX50 micro-
scope equipped with the appropriate filter set and digital camera DP70 (Olympus Optical).
Hydroxybenzoate uptake assays. C. parapsilosis cells were grown in synthetic media supplemented 
with hydroxyaromatic substrate (10 mM) as a sole carbon source (i.e. S3OH, S4OH and SHyd for the uptake of 
[14C]3-hydroxybenzoate, [14C]4-hydroxybenzoate and [14C]3,4-dihydroxybenzoate, respectively) till late expo-
nential phase and harvested by centrifugation (10 min, 3000 g at 4 °C). The pellet was washed once with ice-cold 
water and once with the assay buffer (50 mM Tris-HCl pH 7.5) and then resuspended in the same buffer at an 
OD600 = 90. For each measurement, a 60 μl aliquot of cell suspension was used. The uptake assays were per-
formed in the assay buffer at 28 °C. Labeled substrates (i.e. [carboxyl-14C]3-hydroxybenzoate (55 mCi/mmol), 
[carboxyl-14C]4-hydroxybenzoate (55 mCi/mmol) and [carboxyl-14C]3,4-dihydroxybenzoate (55 mCi/mmol)) 
were purchased from American Radiolabeled Chemicals, Inc. (St. Louis, MO). Uptake was initiated by addition of 
Medium Composition
DMEM + FSB Dulbecco’s Modified Eagle’s Medium (Lonza), 10% (w/v) heat-inactivated fetal bovine serum (EuroClone)
SD 0.67% (w/v) yeast nitrogen base w/o amino acids (Difco), 2% (w/v) glucose
SD + MPA 0.67% (w/v) yeast nitrogen base w/o amino acids (Difco), 2% (w/v) glucose, 200 μg/ml mycophenolic acid (Sigma-Aldrich)
SD1% 0.67% (w/v) yeast nitrogen base w/o amino acids (Difco), 1% (w/v) glucose
SD1% + FBS
0.67% (w/v) yeast nitrogen base w/o amino acids (Difco), 1% (w/v) glucose, 10% (v/v) heat-inactivated fetal bovine serum 
(EuroClone)
S3OH 0.67% (w/v) yeast nitrogen base w/o amino acids (Difco), 10 mM 3-hydroxybenzoate
S4OH 0.67% (w/v) yeast nitrogen base w/o amino acids (Difco), 10 mM 4-hydroxybenzoate
S2,4diOH 0.67% (w/v) yeast nitrogen base w/o amino acids (Difco), 10 mM 2,4-dihydroxybenzoate (β-resorcylate)
S2,5diOH 0.67% (w/v) yeast nitrogen base w/o amino acids (Difco), 10 mM 2,5-dihydroxybenzoate (gentisate)
S3,4diOH 0.67% (w/v) yeast nitrogen base w/o amino acids (Difco), 10 mM 3,4-dihydroxybenzoate (protocatechuate)
SHyd 0.67% (w/v) yeast nitrogen base w/o amino acids (Difco), 10 mM hydroquinone
SRes 0.67% (w/v) yeast nitrogen base w/o amino acids (Difco), 10 mM resorcinol
SEtOH 0.67% (w/v) yeast nitrogen base w/o amino acids (Difco), 2% (v/v) ethanol
SGal + MPA 0.67% (w/v) yeast nitrogen base w/o amino acids (Difco), 2% (w/v) galactose, 200 μg/ml mycophenolic acid
SGly 0.67% (w/v) yeast nitrogen base w/o amino acids (Difco), 3% (w/v) glycerol
YCB + BSA 1.17% (w/v) yeast carbon base (Difco), 2% (w/v) bovine serum albumin
YPD 1% (w/v) yeast extract, 1% (w/v) peptone, 0.5% (w/v) glucose
Table 2. Cultivation media.
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a [14C]-labeled compound to a final concentration 50 μM. Aliquots (75 μl) were taken from the incubation mixture 
(364 μl) at timed intervals, immediately filtered through cellulose membranes (0.45-μm pore size; MF-Millipore) 
and washed twice with 4 ml ice-cold assay buffer. The amount of radioactivity accumulated in the cells was 
determined with a scintillation counter Tri-Carb 2900 TR (Perkin Elmer). The uptake activity was expressed as 
disintegrations per minute (dpm) per mg of cells (dry weight). The effect of a protonophore on the uptake of 
[14C]3-hydroxybenzoate was tested in cells treated for two minutes with 100 µM carbonyl cyanide m-chlorophenyl 
hydrazone (CCCP) prior addition of [14C]-labeled substrate to the uptake assay. Apparent Km and Vmax values for 
the 3-hydroxybenzoate uptake were obtained essentially as described for bacterial GenK transporter14.
Bioinformatic analyses. The following databases were used to identify and analyze the gene and protein 
sequences: Candida Genome Database (http://www.candidagenome.org/)53, Candida Gene Order Browser 
(http://cgob3.ucd.ie/)54, 55; Pfam database (http://pfam.xfam.org/)56, SMART (http://smart.embl-heidelberg.
de/)57, UniProt (http://www.uniprot.org/)58 and Transporter Classification Database (http://www.tcdb.
org/)7. Transmembrane helices were predicted by the TMHMM server v 2.0 (http://www.cbs.dtu.dk/services/
TMHMM/)59 and the secondary structures of transporter proteins were visualized using Protter (http://wlab.ethz.
ch/protter/)60. Amino acid sequences were aligned using the MAFFT algorithm implemented in the Geneious 
package v. 5.6.6 (Biomatters) and the alignments were further processed in the Jalview workbench61.
Phylogenetic analysis. Evolutionary histories of the genes considered were first visually inspected using the 
Maximum Likelihood phylogenies available in PhylomeDB62. Then individual phylogenies were reconstructed 
using these proteins and their closest blast hits in NCBI non-redundant database searched as of January 2017. The 
first 100 blast hits were used for MNX1 and MNX2 genes. For HBT1 and HBT2 this procedure did not render both 
genes within the first 100 hits of each other, but both lists contained common proteins. We thus performed the 
analysis of the combination of both lists. In brief, phylogenies were reconstructed as follows: protein sequences 
of the hits that passed a threshold of similarity (e-value < 10−5) and coverage (>33% aligned over the query 
sequence), were aligned with MUSCLE63 with default parameters, trimmed with trimAl v1.464 to eliminate align-
ment columns with more than 50% gaps. A Maximum Likelihood phylogenetic reconstruction was performed 
with PhyML v365, using the LG model and approximating four rate categories and the fraction of invariable sites 
from the data. Then monophyletic clades containing the seed proteins and other Saccharomycotina species were 
selected. Duplicated sequences and pseudogenes were removed. Subtrees are shown in Fig. 7. Whole trees (in 
Newick format) are provided in Supplementary Files S1–S3.
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